Favorable News Pushes Sequenom Stock Up 57 Percent in November | GenomeWeb

NEW YORK (GenomeWeb News) – Shares of Sequenom climbed 57 percent during the month of November on a string of favorable news for the firm.

Shares of the San Diego-based molecular diagnostics developer topped gainers for the month in the GenomeWeb Daily News Index.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.